Each filer's latest filing for 405552100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
| Pfizer Inc. 13D/A | 0% |
3/24/2025
Event 3/21/2025
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 644 | 701 M | $6.19B |
| 2026 Q2 | 655 | 591 M | $5.52B |
| 2026 Q1 | 636 | 568 M | $5.69B |
| 2025 Q4 | 618 | 566 M | $5.72B |
| 2025 Q3 | 607 | 556 M | $4.98B |
| 2025 Q2 | 635 | 577 M | $5.98B |
| 2025 Q1 | 606 | 570 M | $5.87B |
| 2024 Q4 | 616 | 734 M | $7.01B |
| 2024 Q3 | 592 | 516 M | $5.46B |
| 2024 Q2 | 585 | 520 M | $4.30B |
| 2024 Q1 | 602 | 507 M | $4.31B |
| 2023 Q4 | 594 | 394 M | $3.24B |
| 2023 Q3 | 574 | 391 M | $3.18B |
| 2023 Q2 | 582 | 379 M | $3.17B |
| 2023 Q1 | 580 | 370 M | $3.02B |
| 2022 Q4 | 593 | 337 M | $2.70B |
| 2022 Q3 | 552 | 309 M | $1.88B |